探索参与结肠癌进展的关键基因和机制,基于生物信息学分析
Yongting Lan1, Xiuzhen Yang2, Yulian Wei3
1Department of Gastroenterology, Zibo Central Hospital, Zibo, 255036, Shandong, China.
Applied biochemistry and biotechnology
|January 31, 2024
概括
这项研究确定了CCNB1,CLCA1和PLK4作为抑制结肠癌进展的关键基因,通过减少癌细胞增殖和迁移,同时促进细胞亡. 这些发现为结肠癌治疗提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 结肠癌的进展涉及复杂的分子机制.
- 确定预后生物标志物对于患者的治疗结果至关重要.
研究的目的:
- 为了探索结肠癌进展机制.
- 为了确定与结肠癌患者预后相关的枢纽基因.
主要方法:
- 利用基因表达综合 (GEO) 数据集 (GSE10950,GSE62932) 和 GEO2R 来识别差异表达基因 (DEG).
- 进行了基因本体学 (GO) 和基因和基因组的京都百科全书 (KEGG) 路径分析.
- 使用STRING和Cytoscape识别枢纽基因的构建蛋白质-蛋白质相互作用 (PPI) 网络.
- 使用癌症基因组图谱 (TCGA) 数据和卡普兰-梅尔生存分析验证了与预后相关的枢纽基因.
- 经过实验验证的基因表达和功能作用在结肠癌细胞系 (LOVO) 和正常细胞 (NCM-460) 中,通过RT-qPCR,西斑和功能分析 (增殖,迁移,亡) 进行实验验证.
主要成果:
- 确定了266种常见的DEGs,在细胞循环和代谢途径中富含.
- 发现了10个枢纽基因,其中CCNB1,CLCA1和PLK4被确定与预后有显著关联.
- 证明增加CCNB1,CLCA1和PLK4的表达抑制了结肠癌细胞的增殖和迁移,同时诱导了亡.
结论:
- CCNB1,CLCA1和PLK4被确定为可以抑制结肠癌进展的关键基因.
- 这些基因有可能成为结肠癌治疗的治疗标.
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


